Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Gamma-hydroxybutyrate to promote slow-wave sleep in major depressive disorder: a randomized crossover trial
    Published on 2025-04-14
    8 months ago
  • Prefrontal cortex excitatory neurons show distinct response to heroin-associated cue and social stimulus after prolonged heroin abstinence in mice
    Published on 2025-04-13
    8 months ago
  • Alpha-2 agonism in the locus coeruleus impairs learning driven by negative prediction error
    Published on 2025-04-13
    8 months ago
  • Aversion-induced dopamine reductions predict drug-taking and escape behaviors
    Published on 2025-04-09
    8 months ago
  • Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial
    Published on 2025-04-09
    8 months ago
  • Heritable consequences of paternal heroin use: a role for miR-19b in drug-taking behavior
    Published on 2025-04-05
    8 months ago
  • Correction: Lateral habenula induces cognitive and affective dysfunctions in mice with neuropathic pain via an indirect pathway to the ventral tegmental area
    Published on 2025-04-03
    8 months ago
« Previous 1 … 25 26 27 28 29 … 143 Next »
Journal of Psychopharmacology
  • Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat
    Published on 2024-09-28
    1 year ago
  • Aspirin may be more suitable for patients with major depression: Evidence from two-sample Mendelian randomization analysis
    Published on 2024-09-25
    1 year ago
  • Optimizing the individual dosing of paroxetine in major depressive disorder with therapeutic drug monitoring
    Published on 2024-09-25
    1 year ago
  • Serotonin release by parachloroamphetamine in rats with high and low sociability: High prefrontal release capacity in sociable females
    Published on 2024-09-25
    1 year ago
  • Clinical effects of CYP2D6 phenoconversion in patients with psychosis
    Published on 2024-09-23
    1 year ago
  • Influence of panic disorder and paroxetine on brain functional hubs in drug-free patients
    Published on 2024-09-23
    1 year ago
  • Association between lifetime hallucinogen use and psychological distress varies by sexual identity in a nationally representative sample
    Published on 2024-09-23
    1 year ago
« Previous 1 … 25 26 27 28 29 … 134 Next »
European Neuropsychopharmacology
  • The challenges of using machine learning models in psychiatric research and clinical practice
    Published on 2024-09-06
    1 year ago
  • Donanemab: An innovative solution for Alzheimer’s disease?
    Published on 2024-09-06
    1 year ago
  • Therapeutic effectiveness of anti-inflammatory monoclonal antibodies in psychiatric disorders: Challenges with an imbalanced immune system
    Published on 2024-09-06
    1 year ago
  • Welcome to the jungle plot: An open letter to improve data visualization in meta-analyses
    Published on 2024-09-06
    1 year ago
  • Defining the road to recovery: Cognitive reserve and resilience in severe mental illness
    Published on 2024-09-06
    1 year ago
  • Association between exposure to antidepressants and stimulants and age at onset of mania or psychosis: A retrospective population-based cohort study
    Published on 2024-09-06
    1 year ago
  • Valproate use in psychiatry: New caution for an old friend?
    Published on 2024-09-06
    1 year ago
« Previous 1 … 25 26 27 28 29 … 153 Next »

   Pharma Pub